Serological Approaches for Trypanosoma cruzi Strain Typing.

Trypanosoma cruzi discrete typing units genetic variability high-throughput immunomics serotyping trypomastigote small surface antigen

Journal

Trends in parasitology
ISSN: 1471-5007
Titre abrégé: Trends Parasitol
Pays: England
ID NLM: 100966034

Informations de publication

Date de publication:
03 2021
Historique:
received: 14 10 2020
revised: 04 12 2020
accepted: 08 12 2020
pubmed: 14 1 2021
medline: 4 3 2021
entrez: 13 1 2021
Statut: ppublish

Résumé

Trypanosoma cruzi, the protozoan agent of Chagas' disease, displays a complex population structure made up of multiple strains showing a diverse ecoepidemiological distribution. Parasite genetic variability may be associated with disease outcome, hence stressing the need to develop methods for T. cruzi typing in vivo. Serological typing methods that exploit the presence of host antibodies raised against polymorphic parasite antigens emerge as an appealing approach to address this issue. These techniques are robust, simple, cost-effective, and are not curtailed by methodological/biological limitations intrinsic to available genotyping methods. Here, we critically assess the progress towards T. cruzi serotyping and discuss the opportunity provided by high-throughput immunomics to improve this field.

Identifiants

pubmed: 33436314
pii: S1471-4922(20)30344-5
doi: 10.1016/j.pt.2020.12.002
pmc: PMC8900812
mid: NIHMS1670684
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

214-225

Subventions

Organisme : NIAID NIH HHS
ID : R01 AI123070
Pays : United States

Informations de copyright

Copyright © 2020 Elsevier Ltd. All rights reserved.

Références

Proc Natl Acad Sci U S A. 2010 Nov 23;107(47):20411-6
pubmed: 21059959
Sci Rep. 2018 Feb 16;8(1):3158
pubmed: 29453420
Acta Trop. 2015 Nov;151:166-77
pubmed: 26200788
Nat Microbiol. 2020 Mar;5(3):473-485
pubmed: 32015499
Genome Biol Evol. 2019 Jul 1;11(7):1952-1957
pubmed: 31218350
ACS Infect Dis. 2016 Dec 9;2(12):917-922
pubmed: 27696820
PLoS Negl Trop Dis. 2010 May 18;4(5):e687
pubmed: 20502516
PLoS Pathog. 2009 May;5(5):e1000410
pubmed: 19412340
Lancet. 2018 Jan 6;391(10115):82-94
pubmed: 28673423
Microb Genom. 2018 May;4(5):
pubmed: 29708484
Biochim Biophys Acta Mol Basis Dis. 2020 May 1;1866(5):165692
pubmed: 31972227
PLoS One. 2020 Jan 17;15(1):e0227828
pubmed: 31951634
Clin Vaccine Immunol. 2011 Nov;18(11):1850-5
pubmed: 21880857
PLoS Negl Trop Dis. 2018 Jul 12;12(7):e0006612
pubmed: 30001347
J Infect Dis. 2019 May 24;219(12):1980-1988
pubmed: 30721973
J Mol Diagn. 2015 Sep;17(5):605-15
pubmed: 26320872
Parasitology. 2011 Jul;138(8):995-1002
pubmed: 21518468
Int J Parasitol. 2012 Aug;42(9):797-800
pubmed: 22846784
Mol Cell Proteomics. 2015 Jan;14(1):136-47
pubmed: 25368412
Acta Trop. 2018 Aug;184:38-52
pubmed: 28941731
PLoS Negl Trop Dis. 2016 Aug 29;10(8):e0004792
pubmed: 27571035
Am J Trop Med Hyg. 2011 Jan;84(1):78-84
pubmed: 21212206
Int J Parasitol. 2001 Sep;31(11):1218-26
pubmed: 11513891
PLoS Negl Trop Dis. 2017 Sep 5;11(9):e0005882
pubmed: 28873423
Mol Neurobiol. 2018 Jan;55(1):633-641
pubmed: 27981498
PLoS Negl Trop Dis. 2018 Feb 20;12(2):e0006140
pubmed: 29462135
PLoS Negl Trop Dis. 2014 May 22;8(5):e2892
pubmed: 24852444
Biochem J. 2012 Jun 1;444(2):211-8
pubmed: 22428617
Sci Rep. 2014 Apr 16;4:4703
pubmed: 24736467
PLoS Pathog. 2021 Jan 28;17(1):e1009254
pubmed: 33508020
PLoS Negl Trop Dis. 2017 Oct 9;11(10):e0005972
pubmed: 28991925
Proc Natl Acad Sci U S A. 1993 Feb 15;90(4):1335-9
pubmed: 8433991
PLoS Negl Trop Dis. 2014 Jun 05;8(6):e2906
pubmed: 24901991
Trans R Soc Trop Med Hyg. 2011 Oct;105(10):543-9
pubmed: 21803389
Parasit Vectors. 2015 Sep 17;8:466
pubmed: 26384317
Sci Rep. 2020 Aug 6;10(1):13296
pubmed: 32764546
PLoS Negl Trop Dis. 2018 Nov 12;12(11):e0006939
pubmed: 30418976
Cell Microbiol. 2016 Oct;18(10):1429-43
pubmed: 26918803
Mem Inst Oswaldo Cruz. 1993 Jan-Mar;88(1):161-2
pubmed: 8246752
J Clin Microbiol. 2017 Dec;55(12):3444-3453
pubmed: 28978686
Parasitology. 2012 Apr;139(4):516-21
pubmed: 22309735
PLoS Negl Trop Dis. 2012;6(6):e1707
pubmed: 22745843
Clin Infect Dis. 2010 Sep 1;51(5):485-95
pubmed: 20645859
Front Cell Infect Microbiol. 2021 Mar 03;11:614665
pubmed: 33747978
Trends Parasitol. 2017 Feb;33(2):102-112
pubmed: 27843019
PLoS Negl Trop Dis. 2017 Mar 23;11(3):e0005444
pubmed: 28333926
PLoS Negl Trop Dis. 2017 Aug 11;11(8):e0005856
pubmed: 28800609
Parasit Vectors. 2019 Sep 16;12(1):424
pubmed: 31522683
PLoS Negl Trop Dis. 2018 Apr 2;12(4):e0006351
pubmed: 29608573
Mol Cell Proteomics. 2012 Dec;11(12):1790-800
pubmed: 22984286
Expert Rev Anti Infect Ther. 2015 Aug;13(8):995-1029
pubmed: 26162928
Infect Genet Evol. 2018 Dec;66:229-235
pubmed: 30296602
Sci Rep. 2020 Oct 2;10(1):16395
pubmed: 33009443
Mol Cell Proteomics. 2015 Jul;14(7):1871-84
pubmed: 25922409
Emerg Infect Dis. 2016 Aug;22(8):1452-5
pubmed: 27434772
Int J Parasitol. 2010 Jul;40(8):921-8
pubmed: 20097201
J Immunol Methods. 2016 Jul;434:39-45
pubmed: 27090730
NPJ Vaccines. 2020 May 1;5(1):33
pubmed: 32377398
Acta Trop. 2010 Jul-Aug;115(1-2):14-21
pubmed: 19932071
PLoS Negl Trop Dis. 2013 Oct 31;7(10):e2524
pubmed: 24205430
Sci Rep. 2020 Mar 24;10(1):5294
pubmed: 32210339
Am J Pathol. 2000 May;156(5):1805-9
pubmed: 10793092
Immunology. 2014 Sep;143(1):13-20
pubmed: 24854488
Clin Infect Dis. 2018 Aug 1;67(4):519-524
pubmed: 29438471
PLoS Negl Trop Dis. 2012;6(7):e1777
pubmed: 22860154
Clin Vaccine Immunol. 2015 Mar;22(3):304-12
pubmed: 25589551
Adv Carbohydr Chem Biochem. 2009;62:311-66
pubmed: 19501708
Am J Trop Med Hyg. 2009 Mar;80(3):410-5
pubmed: 19270291
Acta Trop. 2015 Nov;151:32-50
pubmed: 26051910
J Biol Chem. 2012 Jul 27;287(31):26365-76
pubmed: 22707724
PLoS Negl Trop Dis. 2019 Mar 14;13(3):e0007245
pubmed: 30870417
Front Cell Infect Microbiol. 2019 Nov 29;9:408
pubmed: 31850240
Cell Host Microbe. 2019 Nov 13;26(5):579-590.e5
pubmed: 31726028
PLoS Negl Trop Dis. 2017 Sep 29;11(9):e0005986
pubmed: 28961244
Science. 2001 Sep 14;293(5537):2101-5
pubmed: 11474067
PLoS Negl Trop Dis. 2012;6(8):e1779
pubmed: 22905275
Biosens Bioelectron. 2016 Jun 15;80:24-33
pubmed: 26802749
Int J Parasitol. 2009 Apr;39(5):615-23
pubmed: 19041313
Front Immunol. 2018 Dec 11;9:2866
pubmed: 30619257
PLoS Negl Trop Dis. 2020 Oct 1;14(10):e0008418
pubmed: 33001966
PLoS Negl Trop Dis. 2019 Jun 27;13(6):e0007536
pubmed: 31247047
Sci Rep. 2018 Oct 2;8(1):14631
pubmed: 30279473
PLoS Negl Trop Dis. 2013;7(2):e2041
pubmed: 23437405
Parasit Vectors. 2016 Nov 15;9(1):584
pubmed: 27846858
J Exp Med. 2002 Feb 18;195(4):401-13
pubmed: 11854354

Auteurs

Virginia Balouz (V)

Laboratory of Molecular Biology of Protozoa, Instituto de Investigaciones Biotecnológicas 'Dr Rodolfo Ugalde' (IIBio), Universidad Nacional de General San Martín (UNSAM)-CONICET, Buenos Aires, Argentina.

Leonel Bracco (L)

Trypanosomatics Laboratory, Instituto de Investigaciones Biotecnológicas 'Dr Rodolfo Ugalde' (IIBio), Universidad Nacional de General San Martín (UNSAM)-CONICET, Buenos Aires, Argentina.

Alejandro D Ricci (AD)

Trypanosomatics Laboratory, Instituto de Investigaciones Biotecnológicas 'Dr Rodolfo Ugalde' (IIBio), Universidad Nacional de General San Martín (UNSAM)-CONICET, Buenos Aires, Argentina.

Guadalupe Romer (G)

Laboratory of Molecular Biology of Protozoa, Instituto de Investigaciones Biotecnológicas 'Dr Rodolfo Ugalde' (IIBio), Universidad Nacional de General San Martín (UNSAM)-CONICET, Buenos Aires, Argentina.

Fernán Agüero (F)

Trypanosomatics Laboratory, Instituto de Investigaciones Biotecnológicas 'Dr Rodolfo Ugalde' (IIBio), Universidad Nacional de General San Martín (UNSAM)-CONICET, Buenos Aires, Argentina. Electronic address: fernan@iib.unsam.edu.ar.

Carlos A Buscaglia (CA)

Laboratory of Molecular Biology of Protozoa, Instituto de Investigaciones Biotecnológicas 'Dr Rodolfo Ugalde' (IIBio), Universidad Nacional de General San Martín (UNSAM)-CONICET, Buenos Aires, Argentina. Electronic address: cbuscaglia@iib.unsam.edu.ar.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH